Showing results (2271-2280 of 2,589) with videos related to

Sort By:
Pageof 259
Molecular Oncology|December 8, 2015
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancerArjan Gower, Wei-Hsun Hsu, Shuo-Tse Hsu, et al.
Molecular Oncology|December 9, 2015
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationshipsRita A Sakr, Michail Schizas, Jose V Scarpa Carniello, et al.
Molecular Oncology|October 29, 2017
TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migrationSaskia L Gooskens, Timothy D Klasson, Hendrik Gremmels, et al.
Molecular Oncology|December 2, 2017
Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasisMartin Del Castillo Velasco-Herrera, Louise van der Weyden, Jeremie Nsengimana, et al.
Molecular Oncology|November 22, 2017
Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomyJin Meng, Junhua Zhang, Yingjie Xiu, et al.
Molecular Oncology|October 4, 2017
DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cellsLing Xu, Ye Zhang, Xiujuan Qu, et al.
Molecular Oncology|February 22, 2018
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesChrista Haldrup, Anne L Pedersen, Nadia Øgaard, et al.
Molecular Oncology|February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancerJiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Molecular Oncology|March 6, 2018
Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancerYujiao Xie, Yi Zhang, Lutao Du, et al.
Molecular Oncology|January 30, 2018
A robust gene signature for the prediction of early relapse in stage I-III colon cancerWeixing Dai, Yaqi Li, Shaobo Mo, et al.
Pageof 259